高级别恶性神经内分泌肿瘤对奥曲肽和化疗反应的临床评估和帕西瑞肽的体外临床前结果。
关键词: carcinoma neuroendocrine tumors pasireotide somatostatin receptors
Mesh : Humans Octreotide / therapeutic use pharmacology Somatostatin / analogs & derivatives therapeutic use pharmacology Neuroendocrine Tumors / drug therapy Receptors, Somatostatin / analysis Retrospective Studies Male Middle Aged Female Aged Cell Line, Tumor Cell Proliferation / drug effects Adult Antineoplastic Agents, Hormonal / therapeutic use pharmacology Antineoplastic Agents / therapeutic use pharmacology
来 源:
DOI:10.3390/medicina60071039
PDF(Pubmed)